Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes

R. T. Swords, J. Watts, H. P. Erba, J. K. Altman, M. Maris, F. Anwer, Z. Hua, H. Stein, H. Faessel, F. Sedarati, B. J. Dezube, F. J. Giles, B. C. Medeiros, D. J. DeAngelo

Research output: Contribution to journalLetterpeer-review

30 Scopus citations
Original languageEnglish (US)
Article numbere520
JournalBlood Cancer Journal
Issue number2
StatePublished - Feb 3 2017

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this